SCHEMBL5763410

SCHEMBL5763410

CCCCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 6/20 0.70
▸ EGFR P00533 5/20 0.70
▸ SRC P12931 2/20 0.70
▸ FGFR2 P21802 1/20 0.70
▸ FGFR4 P22455 1/20 0.70
▸ FGFR3 P22607 1/20 0.70
▸ PAK1 Q13153 1/20 0.51
▸ SIK1 P57059 1/20 0.50
▸ SIK2 Q9H0K1 1/20 0.50
▸ SIK3 Q9Y2K2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5761151 0.93 FGFR1 (0.73) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5763110 0.89 FGFR1 (0.72) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5764179 0.89 FGFR1 (0.66) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5762809 0.86 FGFR1 (0.63) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5764765 0.85 FGFR1 (0.67) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5764386 0.83 FGFR1 (0.68) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5764483 0.83 FGFR1 (0.67) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL4839269 0.83 FGFR1 (1.00) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5762794 0.82 FGFR1 (0.66) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL5761985 0.82 FGFR1 (0.66) FGFR1EGFRSRCFGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 — — EP claimed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 — — WO claimed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 — — EP claimed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 — — WO claimed
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 — — EP disclosed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 — — WO disclosed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 — — EP disclosed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 — — WO disclosed
Send feedback